Clinical and Microbiological Characteristics of Chryseobacterium indologenes Bacteremia

Journal of Microbiology, Immunology and Infection

Volumn 43, Issue 6, 2010, Pages 498-505

  Lin, Yi Tsung ^a,b   Jeng, Yuan Yu ^a   Lin, Mei Lin ^a   Yu, Kwok Woon ^a,b   Wang, Fu Der ^a,b   Liu, Cheng Yi ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

Antibacterial agents; Bacteremia; Chryseobacterium indologenes

Indexed keywords

ANTIBIOTIC AGENT; CEFEPIME; CIPROFLOXACIN; COTRIMOXAZOLE; LEVOFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CATHETER INFECTION; CENTRAL VENOUS CATHETERIZATION; CHRONIC DRUG ADMINISTRATION; CHRYSEOBACTERIUM INDOLOGENES; CLINICAL ARTICLE; CLINICAL FEATURE; FEMALE; GRAM NEGATIVE SEPSIS; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INDWELLING CATHETER; INTENSIVE CARE UNIT; INVASIVE PROCEDURE; JEJUNOSTOMY; MALE; MINIMUM INHIBITORY CONCENTRATION; MORTALITY; NEUTROPENIA; PARENTERAL NUTRITION; PERCUTANEOUS NEPHROSTOMY; PERITONITIS; POLYMICROBIAL BACTEREMIA; RETROSPECTIVE STUDY; TAIWAN; URINARY CATHETER; URINARY TRACT INFECTION; VENTILATOR;

ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHRYSEOBACTERIUM; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; FEMALE; FLAVOBACTERIACEAE INFECTIONS; HOSPITALS, TEACHING; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; TAIWAN; TREATMENT OUTCOME;

EID: 78650733731     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1684-1182(10)60077-1     Document Type: Article

References (19)

1. Vandamme P, Bernardet JF, Segers P, Kersters K, Holmes B New perspectives in the classification of the flavobacteria: description of Chryseobacterium gen. nov., Bergeyella gen. nov., and Empedobacter nom. rev. Int. J. Syst. Bacteriol 1994, 44:827-831.
2. Yabuuchi E, Hashimoto Y, Ezaki T, Ido Y, Takeuchi N Genotypic and phenotypic differentiation of Flavobacterium indologenes Yabuuchi et al 1983 from Flavobacterium gleum Holmes et al 1984. Microbiol Immunol 1990, 34:73-76.
3. Hsueh PR, Hsiue TR, Wu JJ, Teng LJ, Ho SW, Hsieh WC, et al. Flavobacterium indologenes bacteremia: clinical and microbiological characteristics. Clin Infect Dis 1996, 23:550-555.
4. Hsueh PR, Teng LJ, Ho SW, Hsieh WC, Luh KT Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol 1996, 34:1908-1913.
5. Hsueh PR, Teng LJ, Yang PC, Ho SW, Hsieh WC, Luh KT Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis 1997, 16:568-574.
6. Green BT, Nolan PE Cellulitis and bacteraemia due to Chryseobacterium indologenes. J Infect 2001, 42:219-220.
7. Nulens E, Bussels B, Bols A, Gordts B, Van Landuyt HW Recurrent bacteremia by Chryseobacterium indologenes in an oncology patient with a totally implanted intravascular device. Clin Microbiol Infect 2001, 7:391-393.
8. Lin JT, Wang WS, Yen CC, Liu JH, Chiou TJ, Yang MH, et al. Chryseobacterium indologenes bacteremia in a bone marrow transplant recipient with chronic graft-versus-host disease. Scand J Infect Dis 2003, 35:882-883.
9. Cascio A, Stassi G, Costa GB, Crisafulli G, Rulli I, Ruggeri C, et al. Chryseobacterium indologenes bacteraemia in a diabetic child. J Med Microbiol 2005, 54:677-680.
10. Christakis GB, Perlorentzou SP, Chalkiopoulou I, Athanasiou A, Legakis NJ Chryseobacterium indologenes non-catheter-related bacteremia in a patient with a solid tumor. J Clin Microbiol 2005, 43:2021-2023.
11. Akay M, Gunduz E, Gulbas Z Catheter-related bacteremia due to Chryseobacterium indologenes in a bone marrow transplant recipient. Bone Marrow Transplant 2006, 37:435-436.
12. Bayraktar MR, Aktas E, Ersoy Y, Cicek A, Durmaz R Postoperative Chryseobacterium indologenes bloodstream infection caused by contamination of distillate water. Infect Control Hosp Epidemiol 2007, 28:368-369.
13. Pan HJ, Teng LJ, Chen YC, Hsueh PR, Yang PC, Ho SW, et al. High protease activity of Chryseobacterium indologenes isolates associated with invasive infection. J Microbiol Immunol Infect 2000, 33:223-226.
14. Clinical and Laboratory Standards Institute (CLSI) Performance standards for antimicrobial susceptibility testing. 17th informational supplement 2007, Clinical and Laboratory Standards Institute, Wayne, PA, CLSI document M100-S17.
15. Chang JC, Hsueh PR, Wu JJ, Ho SW, Hsieh WC, Luh KT Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother 1997, 41:1301-1306.
16. Fraser SL, Jorgensen JH Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother 1997, 41:2738-2741.
17. Kirby JT, Sader HS, Walsh TR, Jones RN Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp.: report from the SENTRY Antimicrobial Surveillance Program (1997-2001). J Clin Microbiol 2004, 42:445-448.
18. Marchaim D, Zaidenstein R, Lazarovitch T, Karpuch Y, Ziv T, Weinberger M Epidemiology of bacteremia episodes in a single center: increase in Gram-negative isolates, antibiotics resistance, and patient age. Eur J Clin Microbiol Infect Dis 2008, 27:1045-1051.
19. Hsueh PR, Chen WH, Luh KT Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 2005, 26:463-472.